arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

download Export Data

Immuneering Corp

IMRX

$4.39 ▼ -0.22 (-4.77%) at close

27 Visible periods

22 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Immuneering Corp faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $284.0M

Dividend Yield —

Revenue Growth None

Op. Margin —

ROIC -7.9% ↘

FCF / Share $-0.26 ↗

Trailing P/E —

Price / Book 1.5x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Sep 23, 2026.

27-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$0.00

— —

Net Income Profit after all expenses

$-13.46M

↑ +10.5% —

FCF / Share Free cash flow per share

$-0.26

↑ +10.8% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Revenue Growth YoY (%)	—	—	—	—	—	—	—	—	—	—	—	N/M	N/M	N/M	-99.8% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1347%)	-92.0% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1250%)	-85.7% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1171%)	-75.4% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1043%)	-71.5% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-994%)	-29.4% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-467%)	37.3% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+366%)	—	—	—	—	—	—
EPS Growth YoY (%)	32.5% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	50.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	88.1% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	22.4% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	14.9% Fair ↑ Fair Improving Year-over-year change in earnings per share Optimal: > 10%	14.3% Fair ↑ Fair Improving Year-over-year change in earnings per share Optimal: > 10%	-13.5% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-14.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-9.3% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	3.9% Caution ↑ Caution Improving Year-over-year change in earnings per share Optimal: > 10%	-4.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	12.2% Fair ↑ Fair Improving Year-over-year change in earnings per share Optimal: > 10%	2.3% Caution ↑ Caution Improving Year-over-year change in earnings per share Optimal: > 10%	-4.1% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-900.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-4.3% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	72.7% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	61.1% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	95.8% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	47.2% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	-120.5% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—
Net Income Growth YoY (%)	10.5% Fair ↓ Fair Declining Year-over-year change in net income	10.5% Fair ↑ Fair Improving Year-over-year change in net income	35.9% Excellent ↑ Excellent Improving Year-over-year change in net income	-5.2% Weak ↑ Weak Improving Year-over-year change in net income	-5.2% Weak ↑ Weak Improving Year-over-year change in net income	-5.2% Weak ↑ Weak Improving Year-over-year change in net income	-19.7% Weak ↓ Weak Declining Year-over-year change in net income	-5.2% Weak ↑ Weak Improving Year-over-year change in net income	-5.2% Weak ↑ Weak Improving Year-over-year change in net income	-5.2% Weak ↑ Weak Improving Year-over-year change in net income	-13.9% Weak ↓ Weak Declining Year-over-year change in net income	-5.5% Weak ↑ Weak Improving Year-over-year change in net income	-5.5% Weak ↑ Weak Improving Year-over-year change in net income	-5.5% Weak ↑ Weak Improving Year-over-year change in net income	-22.8% Weak ↑ Weak Improving Year-over-year change in net income	-107.0% Weak ↓ Weak Declining Year-over-year change in net income	-107.0% Weak ↓ Weak Declining Year-over-year change in net income	-107.0% Weak ↓ Weak Declining Year-over-year change in net income	-84.8% Weak ↑ Weak Improving Year-over-year change in net income	-94.6% Weak Weak Year-over-year change in net income	-94.6% Weak Weak Year-over-year change in net income	—	—	—	—	—	—
FCF Growth YoY (%)	—	27.8% Excellent Excellent Year-over-year change in free cash flow	—	—	—	25.0% Good Good Year-over-year change in free cash flow	—	—	—	3.2% Caution Caution Year-over-year change in free cash flow	—	—	—	-16.2% Weak Weak Year-over-year change in free cash flow	—	—	—	62.2% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Profit Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-468.9% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-4008%)	—	—	—
FCF / Net Income (x)	1.23x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	1.38x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.86x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.80x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	—	0.94x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.80x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	1.09x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	0.79x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	1.06x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	0.89x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.96x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.86x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.99x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.94x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	1.09x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Return on Invested Capital (%)	-7.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-5.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-5.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-5.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-40.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-29.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-35.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-20.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-17.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-15.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-14.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-10.6% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-9.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-11.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-10.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-8.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-6.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-7.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-5.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-4.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	17.9% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	17.3% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	20.5% Excellent → Excellent Stable Return earned on debt + equity capital invested Optimal: > 10%	20.6% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	22.3% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—	—
Return on Capital (%) (%)	-9.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-7.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-5.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-6.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-36.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-30.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-35.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-22.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-19.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-17.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-15.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-12.2% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-10.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-13.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-11.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-9.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-8.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-8.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-6.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-5.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-15.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	-15.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—
Return on Common Equity (%) (%)	-7.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-147%)	-6.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-143%)	-5.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-135%)	-6.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-144%)	-52.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-447%)	-36.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-340%)	-43.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-391%)	-24.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-265%)	-21.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-244%)	-18.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-221%)	-16.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-211%)	-13.1% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-187%)	-11.8% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-179%)	-13.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-193%)	-12.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-180%)	-10.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-171%)	-9.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-164%)	-9.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-160%)	-6.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-146%)	-3.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-126%)	17.7% Good ↓ Good Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+18%)	21.8% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+46%)	26.0% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+73%)	19.0% Good Good Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+27%)	25.1% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+67%)	—	—

⚖️ Is the balance sheet risky? 1 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Net Debt (USD)	$-41.32M	$-47.32M	$-128.65M	$-227.56M	$-26.36M	$-35.87M	$-36.14M	$-45.21M	$-59.73M	$-66.29M	$-59.41M	$-68.04M	$-104.02M	$-77.43M	$-72.64M	$-76.42M	$-87.94M	$-75.21M	$-74.89M	$-106.93M	$-50.25M	—	$-37.09M	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Revenue per Share (USD)	—	—	—	—	—	—	—	—	—	—	—	$0.00	$0.00	$0.00	—	$0.00	$0.00	$0.01	—	$0.03	$0.13	$0.15	—	$0.14	$0.10	—	—
Basic EPS, GAAP (USD)	$-0.27	$-0.21	$-0.07	$-0.38	$-0.40	$-0.42	$-0.59	$-0.49	$-0.47	$-0.49	$-0.52	$-0.43	$-0.43	$-0.51	$-0.50	$-0.49	$-0.44	$-0.49	$-0.05	$-0.47	$-1.61	$-1.26	$-1.18	$-0.89	$-0.73	—	—
Free Cash Flow per Share (USD)	$-0.26	$-0.29	—	$-0.30	—	$-0.40	—	—	—	$-0.53	—	—	—	$-0.55	—	—	—	$-0.47	—	—	—	$-1.24	—	$-0.71	—	—	—
Book Value per Share (USD)	$2.95	$3.19	—	$5.75	$0.80	$1.18	—	$1.93	$2.24	$2.68	—	$3.55	$4.02	$3.70	—	$4.62	$5.06	$5.47	—	$8.66	$-7.10	$-5.76	—	$-3.41	$-2.58	—	—
Tangible Book Value per Share (USD)	$2.84	$3.09	—	$5.58	$0.62	$0.99	—	$1.71	$2.01	$2.45	—	$3.33	$3.78	$3.45	—	$4.36	$4.81	$5.21	—	$8.66	$-7.10	$-5.76	—	$-3.41	$-2.58	—	—
Basic Weighted Avg Shares (shares)	64.70M	64.66M	—	39.67M	35.99M	35.53M	—	29.84M	29.65M	29.37M	—	29.27M	28.65M	26.44M	—	26.39M	26.39M	26.36M	—	18.29M	4.95M	4.95M	—	4.95M	4.95M	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Working Capital (USD)	$149.87M	$156.43M	$166.17M	$219.56M	$20.24M	$33.10M	$32.08M	$48.34M	$56.90M	$69.27M	$81.24M	$94.96M	$106.03M	$88.71M	$100.69M	$112.77M	$125.37M	$135.86M	$146.70M	$148.04M	$46.60M	—	$35.48M	—	—	—	—
Total Equity (USD)	$190.74M	$206.52M	$218.48M	$227.98M	$28.94M	$41.84M	$41.39M	$57.72M	$66.31M	$78.72M	$90.58M	$104.02M	$115.10M	$97.79M	$109.85M	$121.89M	$133.59M	$144.06M	$155.98M	$158.29M	$-35.19M	$-28.53M	$-22.48M	$-16.86M	$-12.77M	$-9.46M	$-6.53M

📋 What is driving earnings? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Sales/Revenue/Turnover (USD)	—	—	—	—	—	—	—	—	—	—	—	$0.00	$0.00	$0.00	$455.00	$38.38K	$94.42K	$183.70K	$189.59K	$482.13K	$660.04K	$748.20K	$665.08K	$682.57K	$480.83K	—	—
Depreciation Expense (USD)	$84.45K	$81.40K	$75.89K	$78.84K	$84.53K	$85.26K	$86.12K	$88.95K	$90.53K	$90.21K	$89.75K	$78.29K	$78.24K	$76.53K	$76.86K	$68.08K	$54.56K	$47.70K	$14.81K	$11.98K	$9.81K	$8.87K	$7.45K	$5.66K	$5.92K	—	—
Net Income, GAAP (USD)	$-13.46M	$-13.46M	$-11.58M	$-15.05M	$-15.05M	$-15.05M	$-18.05M	$-14.31M	$-14.31M	$-14.31M	$-15.08M	$-13.60M	$-13.60M	$-13.60M	$-13.25M	$-12.90M	$-12.90M	$-12.90M	$-10.78M	$-6.23M	$-6.23M	$-6.23M	$-5.84M	$-3.20M	$-3.20M	—	—
Operating Cash Flow (USD)	$-16.50M	$-18.43M	$-9.84M	$-11.98M	—	$-14.08M	$-14.51M	—	—	$-15.49M	$-11.78M	—	—	$-14.42M	$-11.75M	—	—	$-12.28M	$-9.24M	—	—	$-6.14M	$-5.45M	$-3.49M	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 7 years · 27 quarters

Immuneering Corp

Analytical Summary

27-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare IMRX with peers